Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,096 signal articles · 349 in last 24h · 114,293 total before filter · latest 18m ago
349last 24h
1924last 7d
313● bullish (7d)
169● bearish (7d)
205publishers
AllMacro320Earnings983M&A100Regulatory24Product18Analyst22
✕ clear all filtersticker: CGNXsentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Why Cognex (CGNX) Shares Are Sliding Today
StockStory1d agoneutral
Why Cognex (CGNX) Shares Are Sliding Today

Shares of machine vision technology company Cognex (NASDAQ:CGNX) fell 4% in the afternoon session after HSBC downgraded the stock to "Hold" from "Buy" and slashed its price target. The bank adjusted its price target on Cognex shares to $65 from $94, reflecting a more cautious outlook on the stock. This move comes amid a backdrop of mixed analyst signals and valuation concerns. For instance, while DA Davidson recently raised its price target to $65 from $62, it maintained a "Neutral" rating, poin

Cognex Sees Record Revenue, Margin Gains as AI Powers Machine-Vision Growth
MarketBeat3d agoneutral
Cognex Sees Record Revenue, Margin Gains as AI Powers Machine-Vision Growth

Cognex (NASDAQ:CGNX) Chief Financial Officer Dennis Fehr said the machine-vision company sees a strong demand backdrop, expects continued margin expansion and views artificial intelligence as a growth catalyst rather than a competitive threat. Speaking at a company news event, Fehr described Cognex

CGNX Q2 Deep Dive: AI-Driven Growth and Product Diversification Shape Outlook
StockStory4d agoneutral
CGNX Q2 Deep Dive: AI-Driven Growth and Product Diversification Shape Outlook

Machine vision technology company Cognex (NASDAQ:CGNX) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 16.9% year on year to $291.3 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $310 million at the midpoint, or 9.9% above analysts’ estimates. Its non-GAAP profit of $0.45 per share was 5.9% above analysts’ consensus estimates.